Danahy Kevin Patrick bought PLSE
September 18, 2025 · Form 4 insider transaction
Danahy Kevin Patrick bought 20,000 shares of Pulse Biosciences, Inc. at $1.53 per share, a transaction worth $30.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$1.53
Total value
$30.6K
InsiderDanahy Kevin Patrick
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 18, 2025
Filing dateSeptember 22, 2025
Shares owned after63,298
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025.